Simpact Ventures

20/04/2026

⁣
FDA clearance #2 for Ligence! Automated LV strain now FDA-cleared. Supporting faster, more consistent echo care for patients. ❤️⁣
⁣
By automating LV Strain, is making a "premium" clinical metric accessible to every echo lab in the US, regardless of their volume or staffing levels. It’s no longer about whether a clinician has the time; it’s about the patient getting the best diagnostic data possible.⁣
⁣
Fantastic news! Congratulations! 👏 ⁣
⁣
Read more:

Lithuania, April 14th, 2026 – Ligence announces it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance for the newest iteration of its AI-powered echocardiography software, Ligence Heart. Building on its initial clearance, the updated platform now features fully automa...

14/04/2026

Big congrats to our portfolio company on hitting 2M downloads 🚀
What’s especially exciting is how clearly this shows the global need for better, more accessible learning tools, and how well is addressing it.

Proud to be on this journey together. More to come 👏
Learn more about Stimy AI here: https://www.simpact.vc/portfolio/stimy-ai/

08/04/2026

⁣
What happens in the information space increasingly translates into real-world outcomes. That’s the layer our portfolio company CulturePulse is working on — understanding how narratives move through groups and why they stick. 🧠⁣
⁣
Not just tracking content, but explaining why people believe, share and act. Their work is based on behavioural science and large-scale simulations of how information moves across groups.⁣
⁣
More in the article published by :⁣
👉 https://teaduspark.ee/en/startup-story-culturepulse-x-nato-diana-estonian-accelerator/⁣

03/04/2026

Happy Easter to everyone celebrating! 🌸
Take a break from the emails, step away from Google Meet & Teams, and enjoy some chocolate, sunshine, and good vibes 🕊️✨💚

23/03/2026

👏 Congratulations to our portfolio company Ligence on launching a new EU-supported project focused on accelerating its international expansion.⁣
⁣
The “𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐋𝐢𝐠𝐞𝐧𝐜𝐞 𝐄𝐱𝐩𝐨𝐫𝐭 𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥” project focuses on two areas: product certification and international exhibitions. The plan is to showcase the solution at 6 events, certify it for the US market and increase export sales.⁣
💶 The project is co-funded by the European Union, with over €51k in support.⁣
⁣
🫀 , a Lithuania-based startup automating echocardiography, continues to expand its impact by improving diagnostic efficiency and enabling faster clinical decision-making in cardiovascular care.

16/03/2026

Last week Kinderpedia, one of our portfolio companies, was recognised with two awards at the Romania Startup Awards organised by ROTSA (Romanian Tech Startups Association).⁣
🏆 Startup of the Year⁣
🏆 EdTech Leader⁣
⁣
🚀 is building an all-in-one platform that helps schools manage teaching, administration and communication with parents in a single environment. A simple idea, solving a very real problem in education systems around the world.⁣
⁣
Well deserved, ! 👏 🫶 ⁣
⁣

11/03/2026

Great to see our portfolio company CulturePulse listed among the 10 most promising startups shaping in 2026 by EU-Startups. 🚀

Founded in Bratislava in 2021, develops AI-powered behavioural modelling technology that helps organisations simulate how groups think and react, supporting better strategic and communication decisions.

Well deserved, CulturePulse 💪 👏
More here:

Continuing with our series highlighting the most promising startups across Europe, it’s time to turn our eye to Slovakia, a Central European country

24/02/2026

On February 19, we joined the Final Demo Day of the Kozminski Impact Booster at Akademia Leona Koźmińskiego - Kozminski University. Simpact Ventures took part as a strategic partner, with Krzysztof Grochowski representing our team.

Big congrats to all the startups who took the stage. 👏🏻
See you at the next edition.

04/02/2026

Follow-on investment in Readmio 🔥 🔥 🔥

Readmio makes storytime interactive with smart voice recognition, giving children a new way to enjoy stories. 📚 With our €1M follow-on investment, the team will accelerate international expansion across Asia, the United States and Latin America, while continuing to improve a product families already love.

Congrats to the founders Jozef Šimko, Radoslav Rajčan and Ilya Novodvorskiy! 👏

👉 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞: https://mycompanypolska.pl/artykul/simpact-ventures-znow-inwestuje-w-readmio-startup-otrzymal-milion-euro-na-aplikacje-do-czytania-bajek/19984

Polski fundusz Simpact Ventures zainwestował 1 milion euro w czeski startup Readmio, dwukrotnie zwiększając kwotę swojego poprzedniego wsparcia. To już druga inwestycja funduszu w ten startup w ostatnim czasie. Środki zostaną przeznaczone na dalszą ekspansję międzynarodową, w tym na rynki...

27/01/2026

has launched an interactive version of , available instantly without booking a demo. 🎉 It lets clinicians quickly understand the product and decide if it makes sense for their daily work.

👀 And for anyone not in cardiology, it’s an easy way to see what Ligence is building and how it works.

👉 Try Ligence here: https://ligence.storylane.io/share/zxgcmncp5qgf

09/01/2026

Our portfolio company, Ligence, has secured 510(k) clearance for its Heart solution. 🎉 This achievement places them among the very first AI-driven cardiac ultrasound automation tools 🫀 from the CEE region to reach this regulatory milestone.⁣
⁣
By automating measurements and generating consistent, standardized reports, Ligence Heart helps clinicians save time and ease workflow bottlenecks caused by manual processes.⁣
⁣
Huge congratulations to Arnas Karužas, Justinas Balčiūnas, M.D., Dovydas Matuliauskas, MD, Antanas Kiziela, Karolis Šablauskas, and the entire Ligence team on this great accomplishment! 👏⁣
⁣
Read more: https://ligence.io/ligence-heart-gains-fda-510k-clearance/

24/12/2025

As the year comes to a close, we’re grateful for the people, ideas and committed teams we get to work with. Wishing you a peaceful holiday season and a bright year ahead.

Happy Holidays from Simpact Ventures🎄🦌